Search Results - "Tawk B"

Hypoxia Methylome Classifier (HDMC) Outperforms Gene Signatures in Identifying HPV-Negative HNSCC Patients at Risk for Locoregional Failure Post Primary Radiochemotherapy: A German Cancer Consortium Radiation Oncology Group (DKTK-ROG) Multicenter Trial.

Authors: Tawk, B. Wirkner, U. Schwager, C. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pe552-e553. 2p.

Subjects: Hypoxemia, Chemoradiotherapy, Oncology, Cancer, Consortia

A Methylome Classifier Identifies Patients at Risk for Locoregional Recurrence after Adjuvant Radiochemotherapy in HPV-DNA negative HNSCC: a Multicenter Trial of the German Cancer Consortium- Radiation Oncology Group (DKTK-ROG).

Authors: Tawk, B. Wirkner, U. Schwager, C. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pS17-S18. 2p.

Subjects: Chemoradiotherapy, Oncology

OC-0076: Insights into the evidence-based practice of hypofractionated radiotherapy in Europe.

Authors: Tawk, B. Rodin, D. Axelsson, G. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS35-S35. 1p.

Subjects: Radiotherapy

Geographic Terms: Europe

OC-0390 TCGA molecular subclassification is prognostic for LRC of HNSCC after postoperative RCTx.

Authors: Linge, A. Tawk, B. Löck, S. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS196-S196. 1p.

Subjects: Neck

OC-0570: Validating gene signatures in locally advanced HNSCC patients treated by PORT-C and in xenografts.

Authors: Patil, S. Linge, A. Tawk, B. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS319-S320. 2p.

Subjects: Genes, Xenografts, Patients

OC-0505 Evidence-based practice in the global setting: an international survey of hypofractionation.

Authors: Rodin, D. Osama, M. Tawk, B. et al.

Source: Radiotherapy & Oncology. 2019 Supplement 1, Vol. 133, pS260-S261. 2p.

Subjects: Surveying (Engineering)

Evidence-Based Practice in the Global Setting: An International Survey of Hypofractionation.

Authors: Rodin, D. Mohamad, O. Tawk, B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2019 Supplement, Vol. 105, pE460-E460. 1p.

Subjects: Intensity modulated radiotherapy, Cervical cancer

Evolution of Proton Therapy and Advanced Radiation Techniques for Retinoblastoma.

Authors: Thaker, N.G. Hasan, S. Tawk, B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Sep2014 Supplement, Vol. 90 Issue 1, pS728-S729. 1p.

Subjects: Retinoblastoma, Proton therapy, Salvage therapy, Cancer radiotherapy, Cell enucleation, Progression-free survival, Therapeutics

OC-0614: Evidence-Based Hypofractionated Radiotherapy Uptake in Europe: An Explorative GIROHERO Analysis.

Authors: Oliveira, C. Defourny, N. Gasparotto, C. et al.

Source: Radiotherapy & Oncology. 2020 Supplement 1, Vol. 152, pS348-S349. 2p.

Superior Prognostic Performance of an Immunohistochemistry Trained DNA-Methylation Based PD-L1 Score in Patients with HNSCC Treated with Radiochemotherapy: A Multicenter Study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Authors: Knoll, M. Balermpas, P. von der Grün, J. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. 2020 Supplement, Vol. 108 Issue 3, pS161-S161. 1p.

A tumor DNA-Methylome derived signature of Hypoxia Identifies HPV-negative head and neck cancer patients at risk for distant metastasis after postoperative radiochemotherapy (PORT-C).

Authors: Tawk B Halec G Rein K et al.

Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2026 Apr; Vol. 217, pp. 111433. Date of Electronic Publication: 2026 Feb 09.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

The impact of tumor metabolic activity assessed by ¹⁸F-FET amino acid PET imaging in particle radiotherapy of high-grade glioma patients.

Authors: Waltenberger M Furkel J Röhrich M et al.

Source: Frontiers in oncology [Front Oncol] 2022 Sep 20; Vol. 12, pp. 901390. Date of Electronic Publication: 2022 Sep 20 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.

Authors: Tawk B Wirkner U Schwager C et al.

Corporate Authors: Tawk B Wirkner U Schwager C et al.

Source: International journal of cancer [Int J Cancer] 2022 Feb 15; Vol. 150 (4), pp. 603-616. Date of Electronic Publication: 2021 Nov 08.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Evolution of a Paradigm Switch in Diagnosis and Treatment of HPV-Driven Head and Neck Cancer-Striking the Balance Between Toxicity and Cure.

Authors: Tawk B Debus J Abdollahi A

Source: Frontiers in pharmacology [Front Pharmacol] 2022 Jan 20; Vol. 12, pp. 753387. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2021).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE

Evaluation of Helium Ion Radiotherapy in Combination with Gemcitabine in Pancreatic Cancer In Vitro.

Authors: Cepni B Tessonnier T Dokic I et al.

Source: Cancers [Cancers (Basel)] 2024 Apr 14; Vol. 16 (8). Date of Electronic Publication: 2024 Apr 14.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Clinical Workflow of Cone Beam Computer Tomography-Based Daily Online Adaptive Radiotherapy with Offline Magnetic Resonance Guidance: The Modular Adaptive Radiotherapy System (MARS).

Authors: Kim JY Tawk B Knoll M et al.

Source: Cancers [Cancers (Basel)] 2024 Mar 19; Vol. 16 (6). Date of Electronic Publication: 2024 Mar 19.

Publication Type: Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy for Cervical Cancer 1: The AIM-C1 Trial.

Authors: Weykamp F Meixner E Arians N et al.

Source: Journal of clinical medicine [J Clin Med] 2024 Feb 07; Vol. 13 (4). Date of Electronic Publication: 2024 Feb 07.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE

Carbon-ion radiotherapy (CIRT) as treatment of pancreatic cancer at HIT: initial radiation plan analysis of the prospective phase II PACK-study.

Authors: Baltazar F Tessonnier T Haberer T et al.

Source: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Nov; Vol. 188, pp. 109872. Date of Electronic Publication: 2023 Aug 25.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE

Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer.

Authors: Schmitt K Molfenter B Laureano NK et al.

Source: International journal of cancer [Int J Cancer] 2019 Dec 15; Vol. 145 (12), pp. 3299-3310. Date of Electronic Publication: 2019 Jun 19.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.

Authors: Tawk B Rein K Schwager C et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Aug 15; Vol. 29 (16), pp. 3051-3064.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE